title: Inter-company collaboration for AIDS Drug Development: perspective on combination studies.
authors.affiliation: Bristol-Myers Squibb Pharmaceutical Research Institute, Department 102, Wallingford, CT 06492, USA.
authors.forename: C
authors.initials: C
authors.lastname: McLaren
authors.forename: M
authors.initials: M
authors.lastname: Elkins
authors.forename: M
authors.initials: M
authors.lastname: Salgo
authors.forename: M
authors.initials: M
authors.lastname: Myers
authors.forename: S
authors.initials: S
authors.lastname: Benoit
authors.forename: M
authors.initials: M
authors.lastname: Warburg
mesh_terms: D002985:Clinical Protocols / Q000592:standards*; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards / Q000706:statistics & numerical data; D003299:Cooperative Behavior; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010361:Patients; D012108:Research Personnel; D014481:United States; D014486:United States Food and Drug Administration